CEROW logo

CEROW Stock

Profile

Full Name:

CERo Therapeutics Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://www.cero.bio

Description:

CERo Therapeutics is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases using its proprietary technology platform.

Key Details

Price

$0.02

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

33.92%

Annual Debt To Equity

-0.09

Beta

-2.97

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with CEROW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.02
CEROW price is $0.02

Price YTD Change

+116.87%
CEROW price is up +116.87% since January 1st

Price All-time High

$0.09
CEROW price is currently -80.00% below its historical high of $0.09

Beta

-2.97
CEROW beta is -2.97

200-day SMA

$0.02
CEROW price is currently -11.33% below its 200-day simple moving average

14-day RSI

61.90
CEROW 14-day relative strength index is 61.90

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+0%
CEROW annual revenue is up +0% over the past 3 years

Annual Net Income 3-Year Change

-11.28%
CEROW annual net profit is down -11.28% over the past 3 years

Annual Operating Profit

-$11.97 M
CEROW annual operaing income is -$11.97 million

Annual Operating Profit 3-Year Change

-3.06%
CEROW annual operaing income is down -3.06% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

33.92%
CEROW annual return on equity is 33.92%

Annual ROA

-104.23%
CEROW annual return on assets is -104.23%

Annual EBIT

-$11.97 M
CEROW annual earnings before interest & taxes is -$11.97 million

Annual EBITDA

-$10.90 M
CEROW annual earnings before interest, taxes, depreciation & amortization is -$10.90 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

6.08
CEROW annual current ratio is 6.08

Annual Total Assets

$11.35 M
CEROW annual total assets is $11.35 million

Annual Current Assets

$7.08 M
CEROW annual total current assets is $7.08 million

Annual Total Liabilities

$46.22 M
CEROW annual total liabilities is $46.22 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-16%
CEROW annual cash flow from operations is down -16% over the past 3 years

Annual CFI 3-Year Change

-13.33%
CEROW annual cash flow from investing activities is down -13.33% over the past 3 years

Annual CFF 3-Year Change

-90.66%
CEROW annual cash flow from financing activities is down -90.66% over the past 3 years

Annual CAPEX

$694.23 K
CEROW annual capital expenditures is $694.23 thousand

Annual CAPEX 3-Year Change

+13.33%
CEROW annual capital expenditures is up +13.33% over the past 3 years

Annual FCF

-$12.40 M
CEROW annual free cash flow is -$12.40 million

Annual FCF 3-Year Change

-15.85%
CEROW annual free cash flow is down -15.85% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of CERo Therapeutics Holdings?
  • What is the ticker symbol for CERo Therapeutics Holdings?
  • Does CERo Therapeutics Holdings pay dividends?
  • What sector is CERo Therapeutics Holdings in?
  • What industry is CERo Therapeutics Holdings in?
  • What country is CERo Therapeutics Holdings based in?
  • Is CERo Therapeutics Holdings in the S&P 500?
  • Is CERo Therapeutics Holdings in the NASDAQ 100?
  • Is CERo Therapeutics Holdings in the Dow Jones?
  • When does CERo Therapeutics Holdings report earnings?

What is the primary business of CERo Therapeutics Holdings?

CERo Therapeutics is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases using its proprietary technology platform.

What is the ticker symbol for CERo Therapeutics Holdings?

The ticker symbol for CERo Therapeutics Holdings is NASDAQ:CEROW

Does CERo Therapeutics Holdings pay dividends?

No, CERo Therapeutics Holdings does not pay dividends

What sector is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Healthcare sector

What industry is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Biotechnology industry

What country is CERo Therapeutics Holdings based in?

CERo Therapeutics Holdings is headquartered in United States

Is CERo Therapeutics Holdings in the S&P 500?

No, CERo Therapeutics Holdings is not included in the S&P 500 index

Is CERo Therapeutics Holdings in the NASDAQ 100?

No, CERo Therapeutics Holdings is not included in the NASDAQ 100 index

Is CERo Therapeutics Holdings in the Dow Jones?

No, CERo Therapeutics Holdings is not included in the Dow Jones index

When does CERo Therapeutics Holdings report earnings?

The date for CERo Therapeutics Holdings's next earnings report has not been announced yet